30-Second Takeaway
- Prophylactic NIV alternating with HFNC after extubation cuts reintubations in high‑risk, non‑hypercapnic ICU patients.
- Individualized PEEP strategies during minimally invasive surgery lower driving pressure and reduce postoperative pulmonary complications.
- SABA overuse in asthma independently increases 1‑year MACE and mortality, supporting tight control of reliever use.
- Combustion‑related air pollutants (NO₂, black carbon) drive incident adult‑onset asthma and COPD in a large national cohort.
- Advanced OSA metrics and reassessment post‑revascularization can refine cardiovascular risk stratification and treatment targeting.
Week ending April 18, 2026
Critical updates in ventilatory support, airway disease, and sleep-disordered breathing for practicing pulmonologists
Prophylactic NIV plus HFNC reduces reintubation in high‑risk, non‑hypercapnic ICU patients
In this pooled post hoc analysis of two multicenter trials, 829 high‑risk, non‑hypercapnic adults were managed after extubation with NIV+HFNC or HFNC alone. NIV alternating with HFNC reduced 7‑day reintubation from 17.6% to 11.8% (absolute difference −5.8%, 95% CI −11.2 to −0.8). Benefits persisted at 48 and 72 hours and through ICU discharge, indicating durable protection against early extubation failure. G‑computation confirmed a similar causal effect size, supporting routine prophylactic NIV in high‑risk, non‑hypercapnic extubations.
Individualized PEEP during minimally invasive surgery cuts postoperative pulmonary complications
This systematic review and meta‑analysis included 30 studies with 3,295 patients undergoing minimally invasive thoracic or abdominal surgery. Individualized PEEP strategies reduced postoperative pulmonary complications versus standard lung‑protective ventilation (RR 0.67, 95% CI 0.56–0.79). They also lowered driving pressures by about 3 cmH₂O, suggesting a mechanistic link via reduced ventilator‑induced lung stress. Findings were consistent across surgical types, with moderate certainty of evidence and low overall risk of bias.
SABA overuse in asthma linked to higher MACE and mortality
Using Taiwan’s national asthma pay‑for‑performance database, 231,970 adults with asthma were followed from 2011–2019. SABA overuse (≥3 canisters/year) was associated with higher 1‑year MACE than acceptable use (2.82 vs 0.99 per 100 person‑years; aHR 1.25, 95% CI 1.12–1.39). Overuse increased risks of non‑fatal MI, ischemic stroke, and all‑cause mortality, but not hemorrhagic stroke. MACE risk rose non‑linearly with SABA use, peaking at 6–8 canisters annually, underscoring the need to curb reliever overreliance.
Traffic‑related pollutants drive incident adult‑onset asthma and COPD in Denmark
This nationwide cohort followed 3.2 million Danish adults ≥30 years for incident hospital‑diagnosed asthma and COPD and obstructive airway medication starts. Interquartile increases in PM2.5, NO₂, and black carbon were each associated with higher asthma and COPD incidence. Associations with NO₂ and black carbon remained robust after adjusting for PM2.5, while PM2.5 associations attenuated or disappeared. Results highlight combustion‑related pollution, especially traffic emissions, as key modifiable drivers of adult‑onset obstructive lung disease.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.